Related Experiment Video
Updated: May 19, 2026

Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
Novel protein scaffolds as emerging therapeutic proteins: from discovery to clinical proof-of-concept
Thierry Wurch1, Alain Pierré, Stéphane Depil
1Institut de Recherches Servier, Oncology R&D Unit, 125 Chemin de Ronde, F-78290 Croissy sur Seine, France. thierry.wurch@fr.netgrs.com
Abstract:
Recent advances in combinatorial protein engineering have made it possible to develop immunoglobulin (Ig)-based and non-Ig protein scaffolds that can potentially substitute for most whole antibody-associated properties and currently translate into biologicals with drug-like properties. During the past 10 years, the most validated scaffolds have reached the clinical development phase and, recently, one of them [Kalbitor(®) (Dyax)] has made it to the market, making these alternative scaffold proteins viable drug candidates in a post-antibody landscape. Interestingly, several scaffolds include an immune-active component as part of their therapeutic mode of action, which yielded spectacular clinical efficacy in some hematological malignancies. Here, we review the most recent clinical advances and analyze their benefits for patients.
Related Concept Videos
Protein-protein Interfaces
Preclinical Development: Overview
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Drug Discovery: Overview
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to form...

